GILD vs IDXX: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

IDXX has stronger fundamentals based on our AI analysis.

GILD
GILEAD SCIENCES, INC.
A
78%
Confidence
VS
IDXX
IDEXX LABORATORIES INC /DE
A+
82%
Confidence

GILD vs IDXX Fundamental Comparison

Metric GILD IDXX
Revenue $7.0B $1.1B
Net Income $2.0B $278.4M
Net Margin 29.0% 24.4%
ROE 8.6% 17.9%
ROA 3.6% 8.2%
Current Ratio 1.97x 1.12x
Debt/Equity 0.94x 0.19x
EPS $1.61 $3.47

Green = Better metric | Red = Weaker metric

View Full GILD Analysis →
View Full IDXX Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Top Rated Undervalued Growth Dividend

You Might Also Compare

GILD vs AAPL IDXX vs MSFT GILD vs GOOGL IDXX vs AMZN

GILD vs IDXX: Frequently Asked Questions

Is GILD or IDXX the better stock in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), IDXX has stronger fundamentals. GILD is graded A (78% confidence) while IDXX is graded A+ (82% confidence). This is not investment advice.

How does GILD compare to IDXX fundamentally?

GILEAD SCIENCES, INC. has ROE of 8.6% vs IDEXX LABORATORIES INC /DE's 17.9%. Net margins are 29.0% vs 24.4% respectively.

Which stock pays higher dividends, GILD or IDXX?

GILD has a dividend yield of N/A or no dividend while IDXX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in GILD or IDXX for long term?

For long-term investing, consider that GILD has a A grade with 78% confidence, while IDXX has a A+ grade with 82% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about GILD vs IDXX?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GILD vs IDXX, the AI consensus favors IDXX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.